MedPath

A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland

Completed
Conditions
Obesity
Interventions
Other: No treatment given
Registration Number
NCT05795166
Lead Sponsor
Novo Nordisk A/S
Brief Summary

The study is intended to understand the distribution of different obesity classes and obesity related diseases (diseases that present along with obesity) in patients with body mass index (BMI) β‰₯ 30 kg/m\^2.

Participants will be asked to give information about their health. They will continue their normal way of life and will not get any medication or additional medical test other than those prescribed to you by their doctor. Participation in the study will last for about 1 day.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1241
Inclusion Criteria
  1. Signed informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  2. Male or female, age greater than or equal to 18 years at the time of inclusion/enrolment in the study.
  3. BMI greater than or equal to 30 Kg/m^2 as measured at the inclusion in the study
Exclusion Criteria
  1. Previous participation in this study. Participation is defined as having given informed consent in this study.
  2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation as judged by physician.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
People with obesityNo treatment givenPatients with obesity coming into the clinic as part of routine visit to their treating physician/general practitioner
Primary Outcome Measures
NameTimeMethod
Percentage of patients with at least one obesity related comorbidity of interest for obesity classes I, II and III pooled across all countriesAt the time of enrolment (Day 1)

% patients with obesity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (20)

Dr. Dozsa Katalin Maria EV

πŸ‡­πŸ‡Ί

BiatorbΓ‘gy, Hungary

ALLMEDICA sp. z o. o.

πŸ‡΅πŸ‡±

Nowy Targ, Poland

Clinmedica Research spzo.o

πŸ‡΅πŸ‡±

Skierniewice, Poland

DC-MED

πŸ‡΅πŸ‡±

Swidnica, Poland

Akademicka Praktyka Medycyny Rodzinnej Bielska Chlabicz Czarnowski Oltarzewska Sawicka Powierza

πŸ‡΅πŸ‡±

BiaΕ‚ystok, Poland

DRC Szentendre

πŸ‡­πŸ‡Ί

Szentendre, Hungary

Co-Medi-Catus Kft.

πŸ‡­πŸ‡Ί

Szigethalom, Hungary

Pecsi Tudomanyegyetem

πŸ‡­πŸ‡Ί

Szentlorinc, Hungary

Niepuliczny Zaklad Opieki Zdrowotnej

πŸ‡΅πŸ‡±

Gizycko, Poland

Przychodnia Vistamed

πŸ‡΅πŸ‡±

Wroclaw, Poland

Centrum Medyczne Pratia Bydgoszcz

πŸ‡΅πŸ‡±

Bydgoszcz, Poland

Bellus Przychodnia Lekarza Rodzinnego

πŸ‡΅πŸ‡±

Ksiaz Wielkopolski, Poland

FutureMeds Olsztyn

πŸ‡΅πŸ‡±

Olsztyn, Poland

Dr. Torzsa Peter Bt.

πŸ‡­πŸ‡Ί

Budapest, Hungary

Niepubliczny Zaklad Opieki Zdrowotnej NZOZ ESKULAP s c

πŸ‡΅πŸ‡±

Koluszki, Poland

Santa Familia Centrum Badan, Profilaktyki i Leczenia

πŸ‡΅πŸ‡±

Lodz, Poland

ETG Warszawa

πŸ‡΅πŸ‡±

Warszawa, Poland

Aloes sp. z.o. o

πŸ‡΅πŸ‡±

Lodz, Poland

Poliklinika Chocen a.s.

πŸ‡¨πŸ‡Ώ

Chocen, Czechia

Samodzielny Publiczny Szpital kliniczny Nr 4 w Lublinie

πŸ‡΅πŸ‡±

Lublin, Poland

Β© Copyright 2025. All Rights Reserved by MedPath